1-4 of 4
Cédric Duclos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements

Ilaria Tanasi, Ibrahima Ba, Nicolas Sirvent, Thorsten Braun, Wendy Cuccuini, Paola Ballerini, Nicolas Duployez, Aline Tanguy-Schmidt, Jérôme Tamburini, Sébastien Maury, Eric Doré, Chantal Himberlin, Cédric Duclos, Patrice Chevallier, Philippe Rousselot, Massimiliano Bonifacio, Hélène Cavé, André Baruchel, Hervé Dombret, Jean Soulier, Judith Landman-Parker, Nicolas Boissel, Emmanuelle Clappier
Journal: Blood
Blood (2019) 134 (16): 1351–1355.
https://doi.org/10.1182/blood.2019001244
Published: 2019
Includes: Supplemental data
Journal Articles

Risk Factors For Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation From Matched Related Or Unrelated Donors

Claire Calmettes, Stephane Vigouroux, MD, Reza Tabrizi, MD, Arnaud Pigneux, MD, PhD, Thibaut Leguay, MD, Krimo Bouabdallah, MD, Marie-Sarah Dilhuydy, MD, Cedric Duclos, MD, Axelle Lascaux, MD, Pierre-Yves Dumas, MD, Sophie Dimicoli-Salazar, MD, Gerald Marit, MD, Noel Milpied, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4595.
https://doi.org/10.1182/blood.V122.21.4595.4595
Published: 2013
Journal Articles

Impact Of Female Donor On Allogeneic Stem Cell Transplantation Outcome Of Male Recipient After T-Cell Depletion By Rabbit Antithymocyte Globulin

Claire Calmettes, Stephane Vigouroux, MD, Reza Tabrizi, MD, Arnaud Pigneux, MD, PhD, Thibaut Leguay, MD, Krimo Bouabdallah, MD, Marie-Sarah Dilhuydy, MD, Cedric Duclos, MD, Axelle Lascaux, MD, Pierre-Yves Dumas, MD, Sophie Dimicoli-Salazar, MD, Gerald Marit, MD, Noel Milpied, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5477.
https://doi.org/10.1182/blood.V122.21.5477.5477
Published: 2013
Journal Articles

Improved Outcome After Allogeneic Stem-Cell Transplantation (SCT) As Compared to Non-Allogeneic SCT Therapies in Patients with High-Risk Peripheral T-Cell Lymphomas in First Response.

Margot Robles, Loic Ysebaert, MD PhD, Stephane Vigouroux, MD, Anne Huynh, MD, Marie Parrens, MD, Krimo Bouabdallah, MD, Reza Tabrizi, MD, Thibaut Leguay, Marie-Sarah Dilhuydy, MD, Arnaud Pigneux, MD, PhD, Axelle Lascaux, Cedric Duclos, Gerald Marit, MD, Noel Milpied, MD
Journal: Blood
Blood (2012) 120 (21): 3111.
https://doi.org/10.1182/blood.V120.21.3111.3111
Published: 2012